Your browser doesn't support javascript.
loading
Osilodrostat (LCI699), a potent 11ß-hydroxylase inhibitor, administered in combination with the multireceptor-targeted somatostatin analog pasireotide: A 13-week study in rats.
Li, Li; Vashisht, Kapil; Boisclair, Julie; Li, Wenkui; Lin, Tsu-Han; Schmid, Herbert A; Kluwe, William; Schoenfeld, Heidi; Hoffmann, Peter.
Afiliación
  • Li L; Preclinical Safety, Novartis Institutes for BioMedical Research, East Hanover, NJ, USA. Electronic address: li1.li@novartis.com.
  • Vashisht K; Preclinical Safety, Novartis Institutes for BioMedical Research, East Hanover, NJ, USA.
  • Boisclair J; Preclinical Safety, Novartis Institutes for BioMedical Research, East Hanover, NJ, USA.
  • Li W; Drug Metabolism and Pharmacokinetics, Novartis Institutes for BioMedical Research, East Hanover, NJ, USA.
  • Lin TH; Drug Metabolism and Pharmacokinetics, Novartis Institutes for BioMedical Research, East Hanover, NJ, USA.
  • Schmid HA; Novartis Oncology Development, Basel, Switzerland.
  • Kluwe W; Preclinical Safety, Novartis Institutes for BioMedical Research, East Hanover, NJ, USA.
  • Schoenfeld H; Preclinical Safety, Novartis Institutes for BioMedical Research, East Hanover, NJ, USA.
  • Hoffmann P; Preclinical Safety, Novartis Institutes for BioMedical Research, East Hanover, NJ, USA.
Toxicol Appl Pharmacol ; 286(3): 224-33, 2015 Aug 01.
Article en En | MEDLINE | ID: mdl-25981165

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Piridinas / Somatostatina / Esteroide 11-beta-Hidroxilasa / Imidazoles Límite: Animals Idioma: En Revista: Toxicol Appl Pharmacol Año: 2015 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Piridinas / Somatostatina / Esteroide 11-beta-Hidroxilasa / Imidazoles Límite: Animals Idioma: En Revista: Toxicol Appl Pharmacol Año: 2015 Tipo del documento: Article